Dr. Sandhya Srinivas, MD

Dr. Srinivas practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Srinivas' NPI, 1205913589, was assigned on November 1, 2006. Dr. Srinivas graduated from Madras Medical College in 1987. Dr. Srinivas holds California license A49392.

Dr. Srinivas' primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Srinivas' primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Srinivas is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Srinivas to 1 more hospital and 1 medical group, each named with a free account. Dr. Srinivas' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Srinivas practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Srinivas' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Srinivas is board certified in medical oncology by the American Board of Internal Medicine. Dr. Srinivas is licensed in California.

Dmand AI lists chronic leukemia, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Srinivas treats.

CMS data shows 1,034 Medicare services from Dr. Srinivas across 7 procedure codes in 2024, for 372 Medicare patients. Medicare paid $119,547 for them.

CMS counts 372 Medicare patients who saw Dr. Srinivas in 2024. The largest group is 75 to 84, with 162 patients. 75% of them have cancer, and 74% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Srinivas' median patient age at 68, with 18% women.

In 2024, Dr. Srinivas wrote 221 Medicare Part D claims for 63 patients. 78% of them were for generic drugs. CMS names the drug for 118 of them, across 6 drugs with 11 or more claims each, at $366,847 in total drug cost. In 2023, CMS named 100 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Srinivas for performance year 2024, reported as part of a group. Dr. Srinivas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Srinivas as offering telehealth.

Dmand AI links 12 papers to Dr. Srinivas, published from 2012 to 2022. 2015 was the busiest year, with 2. The most frequent topics are Antibodies, Monoclonal, Carcinoma, Renal Cell and Everolimus. Dr. Srinivas' most frequent co-authors are Hans Joerg Hammers, MD, PhD, Robert J. Motzer, MD and David Francis McDermott, MD.

Dmand AI links Dr. Srinivas to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Neoplasm Metastasis. Stanford University sponsors the most, 2. Open Payments lists research payments to Dr. Srinivas that name 1 trial.

CMS Open Payments shows 350 general payments to Dr. Srinivas from 31 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. Pfizer Inc. paid the most, $45,084. It also lists 14 research payments totaling $10,677 from 2016 to 2025, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Srinivas, most recently CMS Stage 1 EHR in 2013.

Dr. Srinivas graduated from Madras Medical College in 1987.

Dr. Srinivas is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.